PolyPid's senior management will attend the J.P. Morgan 38th Annual Healthcare Conference, to be held on January 13 - 16, 2020 in San Francisco, California, USA.

PolyPid’s abstract "Improved healing of severe open long bone fractures treated with antibiotic-formulated bone graft during the first surgical intervention post-injury" was accepted for Oral presentation at the 2019 OTA Annual Meeting, to be held in Colorado, Denver, on September 25-28, 2019. The Oral Free Paper will be presented by Prof. Doron Norman, in Paper Session II: Tibia and Knee/Tibial Plateau, on Fri., 9/27/19 at 10:16 AM - 10:22 AM.  

PolyPid will present its product candidate D-PLEX intended to treat peri-implantitis,  in booth no. 413 at the Israeli pavilion, in the Greater New York Dental Meeting, to be held on November 25th - 28th 2018, in the Jacob K. Javits Convention Center, 11th Ave B/W 34th & 39th Street, David Intercontinental hotel, New York.

PolyPid’s abstract “Enhanced bone healing of Gustilo III severe open tibia fractures treated by immediate antibiotic-formulated bone grafting” was accepted for Oral presentation at the 39th SICOT Orthopaedic World Congress, to be held in Montreal, Canada, from 10-13 October 2018. The Oral Free Paper will be presented by Dr. Noam Emanuel, PolyPid’s CTO, as a part of the Trauma Free Papers (Pelvis/Lower Limb) session, currently due to take place on 10/12/2018 at 16:00 - 17:30 in Room 517d.

PolyPid’s abstract “PLEX technology - A lipid-and-polymer-based novel local drug delivery system - from concept to clinical practice” was accepted for Oral presentation at the 11th meeting of the ICRS, to be held on October 7-9, 2018, at the Hacienda Forest View Hotel, Ma'alot Tarshiha. The presentation is scheduled for Sunday, October 7, 2018 from 15:20 until 15:35  in the session entitled:  INNOVATIVE BIO-INSPIRED AND BIOMIMETIC MATERIALS.

PolyPid will participate at IATI BioMed (Biomed Israel 2018), Israel’s 17^th National Life Sciences & technology Week, to be held May 15 - 17, 2018, at the Tel Aviv Convention Center, Israel. The company will be also presenting at the Start Up Pavilion by Israel Innovation Authority, on May 16 (Booth SP16).

PolyPid will participate at the DDF Summit Meeting, to be held in Berlin, Germany.  PolyPid will be represented by Dr. Tamar Alon, PolyPid’s Chief Business Officer. PolyPid will be exploring new collaborations around its revolutionary PLEX™ localized, controlled and prolonged drug delivery platform and products.

PolyPid will participate at the DDP meeting,  to be held in PGA National Resort & Spa, Palm Beach Gardens, FL, US. PolyPid’s poster entitled: “PLEX™ Revolutionizing Medicine by Enabling Localized Controlled and Prolonged Therapeutics” will be presented in the Poster Exhibit Hall. PolyPid will be represented by Dr. Tamar Alon, PolyPid’s Chief Business Officer. PolyPid will be exploring new collaborations around its core PLEX™ local drug delivery platform and products.

PolyPid's senior management will attend the J.P. Morgan 36th Annual Healthcare Conference, to be held on January 8 - 11, 2018 in San Francisco, California, USA.